BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23700716)

  • 1. Chromophobe renal cell carcinoma with sarcomatoid differentiation: a clinicopathologic study of 14 cases.
    Lauer SR; Zhou M; Master VA; Osunkoya AO
    Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):77-84. PubMed ID: 23700716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution.
    Przybycin CG; Cronin AM; Darvishian F; Gopalan A; Al-Ahmadie HA; Fine SW; Chen YB; Bernstein M; Russo P; Reuter VE; Tickoo SK
    Am J Surg Pathol; 2011 Jul; 35(7):962-70. PubMed ID: 21602658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
    de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
    Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
    Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chromophobe renal cell carcinoma: a clinicopathological study of 16 cases].
    Nakaigawa N; Yao M; Kondo K; Kishida T; Noguchi K; Kubota Y; Nagashima Y; Kawano N; Inayama Y; Nozawa A
    Hinyokika Kiyo; 2006 Jan; 52(1):1-6. PubMed ID: 16479980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features on chromophobe renal cell carcinoma].
    Wang ZH; DU LH; Hu ZQ; Chen XG; Zhao X; Wang SG; Zhuang QY; Ye ZQ
    Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):320-3. PubMed ID: 21612697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sarcomatoid renal cell carcinoma: follow-up of a series of 23 patients].
    Pamela A; Arnoux V; Long JA; Rambeaud JJ; Lechevallier E
    Prog Urol; 2014 Apr; 24(5):301-6. PubMed ID: 24674336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
    Diolombi ML; Cheng L; Argani P; Epstein JI
    Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromophobe renal cell carcinoma: analysis of 61 cases.
    Peyromaure M; Misrai V; Thiounn N; Vieillefond A; Zerbib M; Flam TA; Debré B
    Cancer; 2004 Apr; 100(7):1406-10. PubMed ID: 15042674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases.
    Zhang M; Wah C; Epstein JI
    Am J Surg Pathol; 2014 Nov; 38(11):1516-21. PubMed ID: 25140895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
    Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
    Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromophobe renal cell carcinoma with osteosarcoma differentiation: case report and literature review.
    Li YF; Cha TL; Jin JS; Yu CP
    Urol Int; 2010; 85(4):470-4. PubMed ID: 20820103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
    Cheville JC; Lohse CM; Zincke H; Weaver AL; Leibovich BC; Frank I; Blute ML
    Am J Surg Pathol; 2004 Apr; 28(4):435-41. PubMed ID: 15087662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
    Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.